Cargando…
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
Severe acute respiratory syndrome (SARS) is a highly contagious infectious disease which first emerged in late 2002, caused by a then novel human coronavirus, SARS coronavirus (SARS-CoV). The virus is believed to have originated from bats and transmitted to human through intermediate animals such as...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115611/ https://www.ncbi.nlm.nih.gov/pubmed/26954467 http://dx.doi.org/10.1016/j.vaccine.2016.02.063 |
_version_ | 1783514134397059072 |
---|---|
author | Ng, Oi-Wing Chia, Adeline Tan, Anthony T. Jadi, Ramesh S. Leong, Hoe Nam Bertoletti, Antonio Tan, Yee-Joo |
author_facet | Ng, Oi-Wing Chia, Adeline Tan, Anthony T. Jadi, Ramesh S. Leong, Hoe Nam Bertoletti, Antonio Tan, Yee-Joo |
author_sort | Ng, Oi-Wing |
collection | PubMed |
description | Severe acute respiratory syndrome (SARS) is a highly contagious infectious disease which first emerged in late 2002, caused by a then novel human coronavirus, SARS coronavirus (SARS-CoV). The virus is believed to have originated from bats and transmitted to human through intermediate animals such as civet cats. The re-emergence of SARS-CoV remains a valid concern due to the continual persistence of zoonotic SARS-CoVs and SARS-like CoVs (SL-CoVs) in bat reservoirs. In this study, the screening for the presence of SARS-specific T cells in a cohort of three SARS-recovered individuals at 9 and 11 years post-infection was carried out, and all memory T cell responses detected target the SARS-CoV structural proteins. Two CD8(+) T cell responses targeting the SARS-CoV membrane (M) and nucleocapsid (N) proteins were characterized by determining their HLA restriction and minimal T cell epitope regions. Furthermore, these responses were found to persist up to 11 years post-infection. An absence of cross-reactivity of these CD8(+) T cell responses against the newly-emerged Middle East respiratory syndrome coronavirus (MERS-CoV) was also demonstrated. The knowledge of the persistence of SARS-specific celullar immunity targeting the viral structural proteins in SARS-recovered individuals is important in the design and development of SARS vaccines, which are currently unavailable. |
format | Online Article Text |
id | pubmed-7115611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71156112020-04-02 Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection Ng, Oi-Wing Chia, Adeline Tan, Anthony T. Jadi, Ramesh S. Leong, Hoe Nam Bertoletti, Antonio Tan, Yee-Joo Vaccine Article Severe acute respiratory syndrome (SARS) is a highly contagious infectious disease which first emerged in late 2002, caused by a then novel human coronavirus, SARS coronavirus (SARS-CoV). The virus is believed to have originated from bats and transmitted to human through intermediate animals such as civet cats. The re-emergence of SARS-CoV remains a valid concern due to the continual persistence of zoonotic SARS-CoVs and SARS-like CoVs (SL-CoVs) in bat reservoirs. In this study, the screening for the presence of SARS-specific T cells in a cohort of three SARS-recovered individuals at 9 and 11 years post-infection was carried out, and all memory T cell responses detected target the SARS-CoV structural proteins. Two CD8(+) T cell responses targeting the SARS-CoV membrane (M) and nucleocapsid (N) proteins were characterized by determining their HLA restriction and minimal T cell epitope regions. Furthermore, these responses were found to persist up to 11 years post-infection. An absence of cross-reactivity of these CD8(+) T cell responses against the newly-emerged Middle East respiratory syndrome coronavirus (MERS-CoV) was also demonstrated. The knowledge of the persistence of SARS-specific celullar immunity targeting the viral structural proteins in SARS-recovered individuals is important in the design and development of SARS vaccines, which are currently unavailable. Elsevier Ltd. 2016-04-12 2016-03-05 /pmc/articles/PMC7115611/ /pubmed/26954467 http://dx.doi.org/10.1016/j.vaccine.2016.02.063 Text en Copyright © 2016 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ng, Oi-Wing Chia, Adeline Tan, Anthony T. Jadi, Ramesh S. Leong, Hoe Nam Bertoletti, Antonio Tan, Yee-Joo Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection |
title | Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection |
title_full | Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection |
title_fullStr | Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection |
title_full_unstemmed | Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection |
title_short | Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection |
title_sort | memory t cell responses targeting the sars coronavirus persist up to 11 years post-infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115611/ https://www.ncbi.nlm.nih.gov/pubmed/26954467 http://dx.doi.org/10.1016/j.vaccine.2016.02.063 |
work_keys_str_mv | AT ngoiwing memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection AT chiaadeline memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection AT tananthonyt memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection AT jadirameshs memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection AT leonghoenam memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection AT bertolettiantonio memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection AT tanyeejoo memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection |